Zoetis to Present 2024 Financial Results on February 13, 2025

Zoetis Prepares for Q4 and Full Year 2024 Financial Results Presentation

Zoetis Inc., the foremost player in the animal health industry, plans to host a webcast and conference call on February 13, 2025, to discuss its fourth quarter and full year financial results for 2024. The session, which starts at 8:30 a.m. ET, will feature insights from CEO Kristin Peck and CFO Wetteny Joseph. This event provides a platform for financial analysts to engage directly with company leadership, enhancing transparency and allowing stakeholders to better understand the company's performance and strategic direction. Interested parties can access the live webcast through Zoetis' investor relations website, and a replay will be available later in the day.

Founded over seven decades ago, Zoetis has established itself as a vital contributor to animal health globally, focusing on innovative solutions that predict, prevent, detect, and treat animal diseases. The company's extensive portfolio encompasses medicines, vaccines, diagnostics, and technologies utilized in more than 100 countries, catering to a diverse clientele that includes veterinarians, pet owners, and livestock farmers. With a reported revenue of $8.5 billion in 2023 and a workforce of approximately 14,100 employees, Zoetis remains committed to its mission of advancing animal health and enhancing the welfare of animals worldwide, reinforcing its status as a Fortune 500 company.

The upcoming financial results presentation is particularly significant as it coincides with ongoing discussions about Zoetis' market position and operational efficiency. As the company continues to innovate and expand its product offerings, stakeholders are keenly interested in understanding how these developments translate into financial performance. The financial results are anticipated to provide essential insights into Zoetis' growth trajectory and its strategies for maintaining leadership in the highly competitive animal health sector amidst evolving market demands.

In addition to its financial preparations, Zoetis recently received recognition from BetterInvesting Magazine as a "Stock to Study" for its March 2025 issue. This acknowledgment spurs discussions among investors regarding the company’s valuation, highlighting its strong fundamental data, including key metrics such as sales and earnings. BetterInvesting, a nonprofit organization focused on investment education, continues to empower individuals to cultivate financial literacy, underscoring the importance of thorough market analysis before making investment decisions.

As Zoetis approaches its financial results presentation, the company exemplifies a strong commitment to enhancing animal health while maintaining transparency and open communication with its stakeholders. With an eye on innovation and customer satisfaction, Zoetis is well-positioned to navigate future challenges in the animal health landscape.